Plasma pTau181 and pTau217 predict asymptomatic amyloid accumulation equally well as amyloid PET.

Saved in:
Bibliographic Details
Title: Plasma pTau181 and pTau217 predict asymptomatic amyloid accumulation equally well as amyloid PET.
Authors: De Meyer S; Laboratory for Cognitive Neurology, Department of Neurosciences, Leuven Brain Institute (LBI), KU Leuven, 3000 Leuven, Belgium.; Laboratory for Molecular Neurobiomarker Research, Department of Neurosciences, Leuven Brain Institute (LBI), KU Leuven, 3000 Leuven, Belgium., Schaeverbeke JM; Laboratory for Cognitive Neurology, Department of Neurosciences, Leuven Brain Institute (LBI), KU Leuven, 3000 Leuven, Belgium., Luckett ES; Laboratory for Cognitive Neurology, Department of Neurosciences, Leuven Brain Institute (LBI), KU Leuven, 3000 Leuven, Belgium.; Laboratory for Complex Genetics, Department of Human Genetics, KU Leuven, 3000 Leuven, Belgium., Reinartz M; Laboratory for Cognitive Neurology, Department of Neurosciences, Leuven Brain Institute (LBI), KU Leuven, 3000 Leuven, Belgium., Blujdea ER; Neurochemistry Laboratory, Department of Clinical Chemistry, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, 1081 HV Amsterdam, The Netherlands., Cleynen I; Laboratory for Complex Genetics, Department of Human Genetics, KU Leuven, 3000 Leuven, Belgium., Dupont P; Laboratory for Cognitive Neurology, Department of Neurosciences, Leuven Brain Institute (LBI), KU Leuven, 3000 Leuven, Belgium., Van Laere K; Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, 3000 Leuven, Belgium.; Division of Nuclear Medicine, UZ Leuven, 3000 Leuven, Belgium., Vanbrabant J; ADx NeuroSciences NV, 9052 Ghent, Belgium., Stoops E; ADx NeuroSciences NV, 9052 Ghent, Belgium., Vanmechelen E; ADx NeuroSciences NV, 9052 Ghent, Belgium., di Molfetta G; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, S-431 80 Mölndal, Sweden., Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, S-431 80 Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, S-431 80 Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, WC1N 3BG London, UK.; UK Dementia Research Institute at UCL, WC1N 3BG London, UK.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53792, USA., Ashton NJ; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, S-431 80 Mölndal, Sweden., Teunissen CE; Neurochemistry Laboratory, Department of Clinical Chemistry, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, 1081 HV Amsterdam, The Netherlands., Poesen K; Laboratory for Molecular Neurobiomarker Research, Department of Neurosciences, Leuven Brain Institute (LBI), KU Leuven, 3000 Leuven, Belgium.; Laboratory Medicine Department, UZ Leuven, 3000 Leuven, Belgium., Vandenberghe R; Laboratory for Cognitive Neurology, Department of Neurosciences, Leuven Brain Institute (LBI), KU Leuven, 3000 Leuven, Belgium.; Neurology Department, UZ Leuven, 3000 Leuven, Belgium.
Source: Brain communications [Brain Commun] 2024 May 23; Vol. 6 (4), pp. fcae162. Date of Electronic Publication: 2024 May 23 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101755125 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-1297 (Electronic) Linking ISSN: 26321297 NLM ISO Abbreviation: Brain Commun Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2632-1297
DOI:10.1093/braincomms/fcae162